Drug Shortage Report for TUSSIONEX
Report ID | 42990 |
Drug Identification Number | 01916971 |
Brand name | TUSSIONEX |
Common or Proper name | Tussionex Suspension |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCODONE PHENYLTOLOXAMINE |
Strength(s) | 5MG 10MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL |
Packaging size | 500ml |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2018-05-01 |
Actual start date | 2018-05-01 |
Estimated end date | 2018-08-15 |
Actual end date | 2018-07-25 |
Shortage status | Resolved |
Updated date | 2018-07-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-07-26 | French | Compare |
v6 | 2018-07-26 | English | Compare |
v5 | 2018-06-12 | French | Compare |
v4 | 2018-06-12 | English | Compare |
v3 | 2018-05-02 | English | Compare |
v2 | 2018-03-15 | French | Compare |
v1 | 2018-03-15 | English | Compare |
Showing 1 to 7 of 7